29th – 30th March 2017

London, UK

Novotel London West

Welcome to World CDx Europe 2017

The premier European precision medicine event for biomarker, drug development and companion diagnostic specialists

World CDx Europe, now in its 7th year, is the comprehensive, end-to-end event for next generation biomarker discovery, targeted drug and diagnostic development.

We’re dedicated to laying the roadmap to help you rapidly progress from exploratory biomarker to safe, effective and commercially successful precision medicine-CDx combinations

To do this we bring together the who’s who of the pharma, biotech and diagnostic industries with expertise in biomarker, drug and CDx development. The jam-packed two days at World CDx Europe is all about having a candid and disruptive discussion around advancing the successful development, commercialization and healthcare integration of precision medicines and high value diagnostics.

Why Attend World CDx Europe in 2017?

  • Learn best practice in validating emerging biomarkers, stratifying patient populations and defining appropriate responder cut offs to drive clinical success
  • Understand and decipher the cost/benefit analysis of embarking on a CDx strategy for therapies being developed in your portfolio
  • Identify the right diagnostic partners to work with and the right partnership model to define your overarching personalised medicine and CDx strategies to streamline approval and adoption of your drug

Click here to find out more

“The World CDx meetings have a great balance between academia, industry and pharma. They cover a broad range of technical, regulatory, and business issues related to the advancement of personalised medicine. ” - Richard Buller, VP, Clinical Development, Pfizer